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Abstract
Background: Argininemia is rare inborn error of metabolism which, when untreated, presents in late infancy with
growth delay and developmental regression. In developed countries, argininemia is diagnosed early by newborn
screening and is treated immediately with a protein-restricted diet. In developing countries, diagnosis may be
delayed by the assumption that stunting is related to malnutrition alone.
Case presentation: We describe the diagnosis and treatment of argininemia in a 60-month-old Kaqchikel Maya girl
in rural Guatemala. The patient initially presented with severe stunting and developmental regression. The initial
diagnosis of argininemia was made by a screening test in dried blood spots and confirmed with urine and serum
amino acid profiles. The patient was treated with a low-protein diet using locally available foods, leading to
significant improvement in her growth and development.
Conclusions: This case demonstrates that the identification, diagnosis and treatment of IEM in developing
countries are increasingly feasible, as well as ethically imperative. Providers working with malnourished children in
developing countries should suspect IEM in malnourished children who do not respond to standard therapies.
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Background
Argininemia (OMIM #207800), an autosomal recessive
disorder of the urea cycle, is caused by a deficiency in
the activity of the hepatic arginase enzyme (ARG1). It is
thought to be among the rarest of the urea cycle disorders
(UCD), with a global incidence of 1 in 2 million births [1].
Unlike the other UCD, argininemia does not typically
present with neonatal or early childhood hyperammone-
mia. Rather, the disorder emerges between 1 and 4 years
of age, characterized by slowing linear growth and failure
of regular cognitive development [2, 3]. Episodic hyperam-
monemia may occur, but usually does not lead to life-
threatening acute illness. If untreated, argininemia can
cause loss of developmental milestones, spastic diplegia,
and severe intellectual disability.
In developed countries, the early diagnosis of non-
proximal UCD is accomplished by tandem mass spec-
trometry (MS/MS) newborn screening [4]. However, in
most developing countries, these techniques are unavail-
able. Additionally, the exceedingly high prevalence of
chronic undernutrition, as well as the relative lack of ac-
cess to pediatricians, may lead to a failure to consider in-
born errors of metabolism (IEM) in the differential
diagnosis of growth disorders. Here we report on a case
of argininemia diagnosed in a 5-year-old female of
Kaqchikel Maya ethnicity in rural Guatemala who pre-
viously carried a diagnosis of chronic severe malnutri-
tion. Her diagnosis was aided by international partnerships.
We discuss the unique challenges of managing argininemia
in a rural, under-resourced setting.
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Case presentation
A 60-month-old female presented to our clinic in central
Guatemala after developmental delay since late infancy
and developmental regression for 1 year. At this time,
her weight was 9.0 kg and height was 86.3 cm. Accord-
ing to the World Health Organization growth standards,
her height-for-age Z-score was -4.9 and her weight-for-
height Z-score was -3.0, consistent with severe wasting
and severe stunting [5].
The patient was born at term at home following an
uneventful pregnancy. She had never seen a physician,
but was evaluated by several community health workers
and received presumptive community-based therapy for
undernutrition. She is of Kaqchikel Maya descent and
was born in an isolated village in Guatemala. Her parents
were first cousins; there was no family history of severe
childhood illness or death. She exhibited progressive delay
in attaining motor milestones; although she sat independ-
ently (5 months) and crawled (10 months) in a timely
fashion, she did not walk until 2 years. Language and so-
cial development were delayed, and she exhibited only
vocalizations and gestures without meaningful word ac-
quisition. She never attained bladder or bowel sphincter
control. She had no acute severe childhood illnesses, and
received all routine vaccinations according to the national
schedule. She was exclusively breastfed until 1 year of age.
Upon initiation of complementary feeding, she showed a
clear aversion to animal protein and vomited on the rare
occasions that she consumed it. At 4 years of age, 1 year
before presentation to our clinic, the patient ceased walk-
ing, adopted a flexed posture of both lower extremities
with scissoring and rigidity, and restrictive eating lead to
significant weight loss. The patient’s physical exam was
notable for severe under-nutrition, and lower extremity
hypertonicity and spasticity. When supported in a stand-
ing position, she exhibited scissoring and a “tip-toe” pos-
ture. Babinski reflexes were upgoing bilaterally. She
demonstrated an attentive gaze and social smile, but was
nonverbal. Her hair was lighter and coarser than that of
family members. Dietary recall revealed extremely low en-
ergy consumption (52 kcal/kg/day) with low-normal pro-
tein intake (0.93 g/kg/day) exclusively from plant sources.
The family followed the advice of community health
workers to provide dietary supplements, including iron,
vitamin B12 and fortified corn-soy blends, but felt ambiva-
lent about the treatments’ effectiveness.
Blood chemistry showed borderline elevations of lactic
acid (3.3 mmol/L, reference range 0.7-2.1 mmol/L) and
ammonia (87.9 ug/dL, reference range 18-90 ug/dL).
AST (aspartate aminotransferase) and ALT (alanine ami-
notransferase) were 38 IU/L and 50 IU/L, respectively.
TSH (thyroid-stimulating hormone), uric acid, blood
urea nitrogen, creatinine, bilirubin, serum electrolytes,
and complete hematologic profile were uninformative. A
filter paper blood spot was obtained and transported to
the United States by courier. Analysis was conducted by
Perkin Elmer Genetics laboratory (Bridgeville, PA). The
analysis revealed an elevated arginine level of 3.05 mg/dL
(reference range <2.00 mg/dL). On a repeat blood spot, ar-
ginine was again elevated at 2.04 mg/dl. Subsequently
serum and urine samples submitted to the Biochemical
Genetics Laboratory at the Mayo Clinic (Rochester, MN)
for confirmatory testing. Results were remarkable for
serum arginine of 510 nmol/mL (reference range 31 – 132
nmol/mL) and urine orotic acid of 46 mmol/mol of cre-
atinine (reference range undetectable), findings consistent
with a biochemical diagnosis of argininemia.
The mainstay of treatment for argininemia is a
protein-restricted diet [6]. This presents a substantial
challenge in rural Guatemala, where poverty and food
availability prevent many families from providing ad-
equate nutrition for healthy children, much less for special
needs diets. Additionally, there is no access to protein-free
or essential amino acid medical foods or ammonia-
scavenging medications. Corn tortillas, the staple of the
Maya Guatemalan diet, provide 200 kcal and 5.4 g protein
per 100 g [7]. At even fairly nominal levels of consump-
tion, tortillas would easily exceed recommended daily pro-
tein restrictions for a UCD [8]. The family expressed
concern about the cost of other low-protein, high-calorie
foods. In collaboration with the patient’s family, we devel-
oped a customized diet based on locally available food
stuffs, principally oat or corn porridge and affordable
fruits and vegetables. Refined sugar and vegetable oil were
used to augment calories, since these were affordable to
the family. This diet provided 110 kcal/kg/day and 1.5
g/kg/day of locally available protein. For the first 4
weeks following the patient’s diagnosis, a Kaqchikel
Maya-speaking social worker specializing in child nutri-
tion made weekly visits to review dietary intake.
On this nutritional regimen, she gained 3.3 kg in the
first 6 months, and her weight-for-height Z-score im-
proved to -0.9. Importantly, the patient regained de-
velopmental milestones. Six months following her
diagnosis, the patient was able to turn completely
while lying, support her torso from a prone position
and stand briefly while supporting herself. Before
treatment, she was completely immobile. The patient’s
family reported her to be increasingly interactive, and
at 6 months basic verbal language returned. Dietary
adherence was very good and the family quickly
learned to differentiate high- and low-protein foods.
Several 24-h diet recalls demonstrated an average of
94 kcal/kg/day and 1.4 g/kg/day of intact protein.
Conclusions
Here we present a case of late diagnosis of argininemia in
a severely stunted and wasted Maya child in Guatemala.
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Diagnostically, this represented a challenge because of the
Guatemala’s endemic stunting, particularly among the
rural, indigenous population to which our patient belongs.
Indeed, rural indigenous Guatemalan children are likely
the most stunted population in the world [9]. Because
stunting and chronic undernutrition increase susceptibil-
ity to infectious disease, severely stunted children com-
monly present with acute wasting [10]. Furthermore,
severely stunted children can manifest significant cogni-
tive delays and late attainment of motor function [11, 12].
For these reasons, initial attempts by community health
workers to treat this patient for the common malnutrition
syndromes were not unreasonable. However, several fea-
tures of the patient’s presentation, including the loss of de-
velopmental milestones, progressive spastic diplegia, and
highly restrictive eating habits with protein avoidance,
were inconsistent with primary malnutrition, prompting
us to initiate a more thorough medical evaluation. In
addition, her stunting was striking even in comparison
to cohorts of other poor, Maya children, who averaged
102.2 cm at 5 years [13]. This highlights the need for
protocol- and community-based approaches to child
malnutrition in developing countries—potentially in the
form of “warning signs” checklists—to better train
frontline workers on indications for deviating from
protocol and seeking a higher level of care.
The treatment for argininemia requires dietary protein
restriction while providing adequate nitrogen and energy
for optimal growth. We did not have access to essential
amino acid medical foods that typically complement a
low-protein diet to provide total daily protein intake at
or below recommendations for age. In addition, we were
unable to monitor plasma amino acids to evaluate diet-
ary adherence, and extreme poverty limited access to
higher-quality protein. We instituted a mild protein re-
striction of 1 to 1.5 g protein/kg, emphasizing comple-
mentary vegetable proteins (e.g., beans and corn). This
diet was financially acceptable to the patient’s family,
and actually increased the child’s pretreatment protein
intake to promote catch-up growth, prevent catabolism,
and provide essential amino acids.
Confirming the diagnosis of an IEM in a developing
country is challenging given the lack of laboratories that
conduct newborn screening and esoteric confirmatory
testing. Guatemala’s two largest public hospitals, located
in the capital, have small in-house screening programs
for detecting congenital hypothyroidism, phenylketon-
uria, congenital adrenal hyperplasia, and galactosemia
only [14]. Our experience offers insight into ways to im-
prove diagnosis and management of UCDs in resource-
poor settings. Given the stability of filter paper blood
samples, we suggest that international processing in a
reference laboratory with extended newborn screening
capabilities is a rapid, cost-effective mechanism for
advancing the diagnostic workup of children in whom
metabolic illness is suspected. We acknowledge that
confirmatory testing remains problematic and expensive,
especially when scarce funds must be allocated to pro-
vide the most societal benefit. However, when evaluating
severe presentations of long-standing malnutrition in a
referral center such as ours, there is an important need
to reconsider the clinical presentation and available data
and to broaden the differential diagnosis and workup
where resources allow. We suggest that global health prac-
titioners working with children with complex medical ill-
nesses should consider building capacity for collecting,
transporting, and processing filter paper specimens.
Finally, the diagnosis and management of IEM in de-
veloping countries is frequently assumed to be logistic-
ally and financially untenable. Indeed, the medical foods
and ammonia-scavenging medications typically used in
managing UCDs are not available where we work, nor
are laboratory tests for monitoring plasma amino acids.
However, our patient had a remarkable clinical response
to simple nutritional therapy, including careful total pro-
tein restriction with global calorie augmentation using
economical local foods. Her case underscores the in-
estimable benefit of case management and nutrition in
under-resourced, global health contexts.
Consent
Verbal informed consent in Kaqchikel Maya was ob-
tained from the patient’s mother and grandmother, her
legal guardians. Verbal consent was deemed to be more
ethical than written because the guardians do not speak
Spanish or English and cannot read or write. This was
done in accordance with the medical organization’s
Statement on Informed Consent in Minority Groups
(available upon request). The interpreter who partici-
pated in the consent signed a witness statement agreeing
that it was performed in accordance with ethical princi-
ples (also available upon request).
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